MedPath

Augmented-Reality CTA Plus Angiography vs Angiography Alone for Guiding PCI in Coronary Lesions - Randomized Study

Not Applicable
Conditions
Coronary Artery Disease
Interventions
Procedure: Angiographic guided PCI
Procedure: Augmented-Reality CTA guided PCI
Registration Number
NCT03531424
Lead Sponsor
Paul Knaapen
Brief Summary

The purpose of this study is to compare revascularization strategy and its immediate results after augmented-reality computed tomography angiography (CTA) guided vs. standard angiography guided percutaneous coronary intervention (PCI) in native coronary lesions.

Detailed Description

While stand-alone angiography is the first-line imaging modality for guidance of PCI, it has some inherent limitations which may result in suboptimal stent placement related to residual reference segment disease and stent underexpansion. Coronary CTA, on the other hand, can provide reliable measurements of the vessel size and lesion length as well as the visualization of the morphological features of coronary plaque, and has been suggested as potentially valuable for changing PCI technique. The AR-PCI trial has been designed as a single-center, investigator initiated and investigator sponsored, randomized (1:1), controlled, prospective clinical trial. It is hypothesized that the review of CTA datasets using augmented-reality glass in the catheterization laboratory could influence PCI treatment strategy and its immediate results by more adequate lesion coverage with less residual disease and better stent expansion as compared to traditional angiography-guided PCI alone.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • patients with documented obstructive CAD defined as the presence of at least 1 stenosis ≥70% in a native coronary artery in whom PCI is considered based on clinical grounds
Exclusion Criteria
  • refusal or inability to provide written informed consent
  • subjects in whom the quality of coronary CTA is insufficient
  • bifurcation lesions, by which strategies other than a single cross-over stent technique are anticipated
  • left main coronary artery stenosis
  • chronic total occlusion
  • in-stent restenosis
  • chronic renal failure (estimated glomerular filtration rate <30 ml/min)
  • known allergy to contrast
  • untreated hyperthyroidism
  • pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Angiographic guided PCIAngiographic guided PCIAngiographic guided PCI is coronary revascularization based on stand-alone angiography.
CTA guided PCIAugmented-Reality CTA guided PCICTA guided PCI is coronary revascularization based on systematic use of CTA plus coronary angiography.
Primary Outcome Measures
NameTimeMethod
Stent length1 day

Length of the stented segment

Predicted stent diameter1 day

Predicted final stent diameter according to a compliance chart

Secondary Outcome Measures
NameTimeMethod
Post-procedural volume of the reference segments1 day

Post-procedural volume of the reference segments by 3D QCA

Nominal stent diameter1 day

Nominal diameter of the implanted stent

Number of stents1 day

Total number of stents

Predilation1 day

Balloon predilation for lesion modification

Maximal balloon pressure1 day

Maximal balloon pressure applied during PCI

Maximal balloon diameter1 day

Maximal balloon diameter applied during PCI

Post-procedural residual area stenosis1 day

Post-procedural residual area stenosis by 3D QCA

Post-procedural minimum lumen diameter1 day

Post-procedural minimum lumen diameter by 3D QCA

Postdilation1 day

Balloon postdilation for stent expansion

Stent-edge dissection1 day

Stent-edge dissection by coronary angiography

Post-procedural residual diameter stenosis1 day

Post-procedural residual diameter stenosis by 3D QCA

Post-procedural minimum lumen area1 day

Post-procedural minimum lumen area by 3D QCA

Post-procedural lumen diameters at the reference segments1 day

Post-procedural lumen diameters at the reference segments by 3D QCA

Post-procedural lumen areas at the reference segments1 day

Post-procedural lumen areas at the reference segments by 3D QCA

Post-procedural volume of the stented segment1 day

Post-procedural volume of the stented segment by 3D QCA

Trial Locations

Locations (1)

VU University Medical Center Amsterdam

🇳🇱

Amsterdam, De Boelelaan 1117, Netherlands

© Copyright 2025. All Rights Reserved by MedPath